izpis_h1_title_alt

Antiphospholipid syndrome in children
ID Zajc Avramovič, Mojca (Avtor), ID Avčin, Tadej (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (1,07 MB)
MD5: 14F741FFE023363B2C9D900A5E1F65A7
URLURL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S1521694224000573 Povezava se odpre v novem oknu

Izvleček
Antiphospholipid syndrome (APS) in children is a rare disease associated with significant morbidity and mortality. In comparison with APS in adults, pediatric APS has a more severe presentation with frequent recurrences of thrombotic events and a higher probability of life-threatening catastrophic APS. Nonthrombotic manifestations are also more common in the pediatric age group and can precede thrombosis. New classification criteria have been introduced recently and have not yet been assessed in pediatric patients with APS. In addition to anticoagulation drugs, other novel therapies have emerged including the use of B cell and complement inhibitors, especially in catastrophic APS. The purpose of this review is to provide a broad overview of aPL-related clinical manifestations in pediatric patients based on the analysis of published cohorts and data from the international pediatric APS registry. We also aim to illustrate APS in infants caused by transplacentally transferred maternal aPL, which is very rarely associated with acute thrombotic events in the perinatal period and more frequently with long-term neurodevelopmental abnormalities.

Jezik:Angleški jezik
Ključne besede:catastrophic antiphospholipid syndrome, children, infants antiphospholipid syndrome, systemic lupus erythematosus, antiphospholipid antibodies, thrombosis, thrombocytopenia, chorea, lupus anticoagulants, anticardiolipin antibodies, anti-β2 glycoprotein I antibodies
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:15 str.
Številčenje:Vol. 38, iss. 3, art. 101986
PID:20.500.12556/RUL-162552 Povezava se odpre v novem oknu
UDK:61
ISSN pri članku:1532-1770
DOI:10.1016/j.berh.2024.101986 Povezava se odpre v novem oknu
COBISS.SI-ID:204888323 Povezava se odpre v novem oknu
Datum objave v RUL:25.09.2024
Število ogledov:53
Število prenosov:11
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Baillière's best practice and research in clinical rheumatology
Skrajšan naslov:Baillière's best pract. res. clin. rheumatol.
Založnik:Elsevier
ISSN:1532-1770
COBISS.SI-ID:204885507 Povezava se odpre v novem oknu

Licence

Licenca:CC BY-NC 4.0, Creative Commons Priznanje avtorstva-Nekomercialno 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc/4.0/deed.sl
Opis:Licenca Creative Commons, ki prepoveduje komercialno uporabo, vendar uporabniki ne rabijo upravljati materialnih avtorskih pravic na izpeljanih delih z enako licenco.

Projekti

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J3-3061
Naslov:Klinične, imunološke in genetske značilnosti večorganskega vnetnega sindroma, povezanega s COVID-19, pri otrocih in mladostnikih

Financer:Drugi - Drug financer ali več financerjev
Program financ.:University Medical Centre Ljubljana
Številka projekta:20210069

Financer:Drugi - Drug financer ali več financerjev
Program financ.:University Medical Centre Ljubljana
Številka projekta:20220090

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj